Waypoint Bio Appoints Dr. Patrick Kaifosh as Chief Technology Officer
PRIVATEJun 01, 2026
Position
Chief Technology Officer
Company
Waypoint Bio
Patrick Kaifosh
New YorkBiotechnologyHealth CareTherapeutics
Description
Waypoint Bio has appointed Dr. Patrick Kaifosh as Chief Technology Officer to strengthen its leadership in AI and automation. This appointment comes as the company secures a $20M Series A funding round to advance its AI-designed CAR T therapies.
Who to call at Waypoint Bio, and when
A new leader at Waypoint Bio brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Waypoint Bio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Waypoint Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Waypoint Bio. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Waypoint Bio
Location
New York, New York, United States
About
Waypoint Bio is a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology. The company's platform uniquely combines spatial biology with pooled screening for the purpose of drug discovery, enabling the simultaneous measurement of cell therapy candidates' navigation in the solid tumor microenvironment. Waypoint will use its seed financing toward designing CAR T-cell therapies with superior efficacy against the tumor microenvironment, and later, Treg therapies for autoimmune diseases.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Waypoint Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
New YorkBiotechnologyHealth CareTherapeutics